Search terms included combinations of the following keywords and Medical Subject Headings (MeSH): “metabolic dysfunction-associated steatotic liver disease”, “MASLD”, “metabolic dysfunction-associated steatohepatitis”, “MASH”, “nonalcoholic fatty liver disease”, “NAFLD”, “cardiovascular risk”, “cardiometabolic disease”, “heart failure”, “atherosclerosis”, “arrhythmia”, “diabetes”, “GLP-1 receptor agonists”, “SGLT2 inhibitors”, and “treatment”. Here, SLC5A2 is linked to metabolic dysfunction-associated steatotic liver disease.